News & Articles
How To Build Strategic Readiness For First-In-Human Studies
Moving from IND submission to first patient enrollment requires more than regulatory […]
Read More....Charting the Path to First-in-Human Studies: Strategic Planning for Early Clinical Success
The transition to first-in-human studies is one of the most significant and […]
Read More....inSpired by Noelle
When Rare Becomes Personal: Noelle’s Story of Advocacy, Survival, and Purpose In […]
Read More....Avoid the Wrecking Ball: Targeted Solutions for Struggling Trials
When clinical trials begin to veer off course, the instinctive response is […]
Read More....Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success
As clinical trials become more complex, traditional monitoring models are increasingly difficult […]
Read More....Press Release for the SQA Board of Directors
FOR IMMEDIATE RELEASE inSeption Group Congratulates Dawn Niccum on Election to the […]
Read More....Founders Forward Focus Forum: Interview with Joe Arcangelo
If you want a real look into what drives InSeption Group’s culture, […]
Read More....Streamlining Clinical Data Management
In clinical development, data management should be a strategic advantage — not […]
Read More....Regulatory Submission Crisis Rescue
In today’s highly competitive development landscape, a regulatory submission can unravel quickly—and […]
Read More....Philadelphia Business Journal Thought Leadership: Life Sciences
We’re proud to share that Robin Johnson, PharmD, Gene Therapy Submissions Lead […]
Read More....